Related Experiment Video
Updated: May 1, 2026
04:27
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
5.4K
Ureaplasma and bronchopulmonary dysplasia
Paolo Gancia1, Antonio Delogu1, Giulia Pomero1
1Terapia Intensiva Neonatale-Neonatologia, ASO S. Croce e Carle, Cuneo, Italy.
Early Human Development
|April 9, 2014
Summary
Ureaplasma infection in premature infants may worsen lung inflammation and increase the risk of bronchopulmonary dysplasia (BPD). More research is needed to determine if antibiotics reduce BPD and improve neurodevelopment.
Area of Science:
- Neonatal Medicine
- Pulmonology
- Infectious Diseases
Background:
- Neonatal intensive care advances improve survival for extremely premature infants (<26 weeks gestation).
- Bronchopulmonary dysplasia (BPD), a lung condition, can arise from disrupted airway growth due to oxygen and ventilation in premature infants.
- Ureaplasma infection in premature infants can trigger lung inflammation and fibrosis, potentially increasing BPD risk.
Purpose of the Study:
- To investigate the role of Ureaplasma infection in the development of bronchopulmonary dysplasia (BPD) in premature infants.
- To evaluate the potential impact of Ureaplasma infection on lung inflammation and its exacerbation by oxygen and ventilation.
- To assess the current evidence regarding antibiotic treatment for Ureaplasma and its effect on BPD development and comorbidities.
Main Methods:
- Review of existing clinical studies on Ureaplasma infection in premature infants.
- Analysis of factors contributing to BPD pathogenesis, including oxygen exposure and mechanical ventilation.
- Identification of gaps in current research regarding Ureaplasma's role and treatment efficacy.
Main Results:
- The precise role of Ureaplasma in BPD pathogenesis remains unclear.
- Insufficient evidence exists to confirm if antibiotic treatment for Ureaplasma influences BPD development or its associated conditions.
- Inflammation associated with Ureaplasma infection may be aggravated by oxygen and mechanical ventilation.
Conclusions:
- Further well-designed clinical trials are necessary to elucidate Ureaplasma's role in BPD.
- Research should focus on determining if treating Ureaplasma reduces lung inflammation, BPD rates, and improves long-term neurodevelopmental outcomes.
- Clarifying the impact of Ureaplasma infection and its treatment is crucial for optimizing care for extremely premature infants.
More Related Videos
Related Concept Videos
01:29Pneumonia I: Introduction
24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
01:30Pneumonia I: Introduction
1.5K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
01:17Pulmonary Cycle: Exhalation
5.2K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K
01:14Atypical Pneumonia
84
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48